Deccan Health Care: Q4 FY26 Profit Soars 91.2% on Strong Revenue Growth

Deccan Health Care Limited has announced robust financial results for the fiscal year ended March 31, 2026. The company reported a substantial 18.69% increase in standalone revenue, reaching ₹8,917.10 Lakhs. Profit After Tax (PAT) saw a remarkable surge of 91.21% to ₹229.05 Lakhs, underscoring significant operational efficiency and a strong earnings performance.

Deccan Health Care Reports Strong Financial Performance for FY 2025-26

Deccan Health Care Limited (DHCL) today announced its financial results for the fiscal year ended March 31, 2026, showcasing significant growth across key financial metrics. The company demonstrated strong operational performance, with standalone revenue increasing by approximately 18.69% to ₹8,917.10 Lakhs, compared to ₹7,513.19 Lakhs in the corresponding period of the previous year.

Profitability Surge and Enhanced Earnings

The company delivered a robust improvement in profitability during the period, with Profit After Tax (PAT) increasing by a remarkable 91.21% to ₹229.05 Lakhs, compared to ₹119.79 Lakhs in the corresponding period of the previous year. Basic Earnings Per Share (EPS) also saw a significant rise of 66.01%, from ₹0.56 to ₹0.93, reflecting an improved earnings performance.

Consolidated Performance Highlights

On a consolidated basis, Revenue from Operations also experienced healthy growth, increasing by approximately 9.12% to ₹8,190.48 Lakhs compared to ₹7,505.79 Lakhs in the corresponding period last year. The consolidated Profit After Tax reflects substantial growth, up by approximately 114.69%, reaching ₹248.76 Lakhs from ₹115.87 Lakhs in the corresponding period last year.

Key Financial Ratios Indicate Strong Growth

Several key financial ratios highlight the company’s positive trajectory. The Debt-Equity Ratio increased from 0.01 times to 0.04 times, attributed to higher borrowings during the year. The Inventory Turnover Ratio improved to 1.59 times, indicating efficient inventory management. The Net Profit Ratio improved significantly from 1.59% to 2.57%, demonstrating enhanced profitability.

Source: BSE

Previous Article

Eris Lifesciences: Clarifies Loan Article, Reaffirms Disclosure

Next Article

Bharat Petroleum: Auditors Appointed for FY27